Accessibility Menu
Cresco Labs logo

Cresco Labs(OTC) CRLBF

Market Cap$236.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-85%
5 Year-94%
1 Year+7%
1 Month-21%
$0.64
+0.61%
+0.00Today
Cresco Labs last closing stock price
MetricPriceDate
Last closeUSD 0.642026-07-29
Cresco Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.87%USD 0.712026-07-22
1 month-20.93%USD 0.812026-06-29
3 month-41.14%USD 1.092026-04-30
Year to date-47.84%USD 1.232025-12-31
1 year+6.86%USD 0.602025-07-29
3 year-59.24%USD 1.572023-07-28
5 year-93.98%USD 10.652021-07-30
Since inception-85.31%USD 4.342018-12-04

Cresco Labs Financials at a Glance

Market Cap

$236.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$641.80M

Net Income (TTM)

-$136.60M

EPS (TTM)

-$0.37

P/E Ratio

-1.71

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$0.64

Volume

276,186

Open

$0.66

Previous Close

$0.64

Daily Range

$0.59 - $0.67

52-Week Range

$0.54 - $2.30

Estimated Earnings Date

Aug 6, 2026

CRLBF News

person holding gummy bear edible an inch from her mouth

4 Best CBD Stocks for 2026 and How to Invest

Keith SpeightsJul 13, 2026
A cannabis leaf on top of a $100 bill.

Best Cannabis ETFs to Buy in 2026 and How to Invest

Keith SpeightsMay 8, 2026
Person lighting and consuming a marijuana cigarette

If You'd Invested $1,000 in CRLBF 5 Years Ago, Here's How Much You'd Have Today

Eric VolkmanAug 30, 2025
A farmer holding a tablet in a hemp field.

The Best Cannabis Stock to Invest $1,000 in Right Now

David Jagielski, CPAApr 17, 2024
A person examining a cannabis plant.

2 Marijuana Companies That Have Recently Turned Profits

David Jagielski, CPAMar 27, 2024
A couple working inside of a greenhouse.

2 Cannabis Stocks to Buy Hand Over Fist in March

David Jagielski, CPAMar 9, 2024
farmer inspects marijuana plant in greenhouse

Where Will Cresco Labs Be in 3 Years?

Alex CarchidiOct 18, 2023
A couple working inside of a greenhouse.

3 Top Cannabis Stocks to Buy for September

David Jagielski, CPASep 8, 2023
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cresco Labs

Cresco Labs Inc. is a leading company in the cannabis industry, focusing on cultivating medical-grade cannabis and manufacturing related products. The company is dedicated to regulatory compliance and developing condition-specific cannabis strains for both medical and adult-use consumers.

Products and Services
  • Cultivation of medical-grade cannabis
  • Manufacturing of cannabis-derived products
  • Distribution to medical and adult-use consumers
Growth Outlook
  • Expansion into new markets is anticipated as regulations evolve
  • Increased consumer demand for cannabis products is projected
  • Focus on innovative delivery methods may enhance market position
Financial Highlights
  • Recent quarterly revenue of 149.2 million reflects a strong market presence
  • Gross profit margin of 46.6% indicates effective cost management
  • Current ratio of 2.51 suggests strong liquidity and financial health
Cresco Labs Inc. operates in a rapidly growing sector, with a focus on compliance and product quality. The company's commitment to innovation and market expansion positions it well for future growth. Recent financial performance shows promising revenue figures and a solid gross profit margin, indicating effective management strategies. The strong current ratio further highlights the company's ability to meet short-term obligations, making it an intriguing option for potential investors interested in the cannabis industry.
AI Generated • Jul 21, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,900

CEO

Charles Bachtell

Website

www.crescolabs.com

Headquarters

Chicago, IL 60661, US

CRLBF Financials

Key Financial Metrics (TTM)

Gross Margin

48.57%

Operating Margin

10.41%

Net Income Margin

-21.28%

Return on Equity

-35.26%

Return on Capital

10.74%

Return on Assets

-11.36%

Earnings Yield

-58.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$236.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

371.00M

Volume

276.19K

Avg. Volume

596.93K

Financials (TTM)

Gross Profit

$311.73M

Operating Income

$66.80M

EBITDA

$108.21M

Operating Cash Flow

$37.32M

Capital Expenditure

-$37.54M

Free Cash Flow

-$219.72K

Cash & ST Invst.

$63.78M

Total Debt

$588.71M

Cresco Labs Performance Analysis

Cresco Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 842,681,0002.6%
20232023-12-31USD 770,885,000-8.5%
20242024-12-31USD 724,343,000-6.0%
20252025-12-31USD 655,847,000-9.5%
Cresco Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-1.3%
Q32025-09-300.8%
Q42025-12-31-0.5%
Q12026-03-31-9.0%
Cresco Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.71-41.6%
20232023-12-31USD -0.54-23.8%
20242024-12-31USD -0.22-60.2%
20252025-12-31USD -0.3877.0%
Cresco Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-12.2%
Q32025-09-30-3.0%
Q42025-12-31-468.4%
Q12026-03-3186.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$149.23M

-10.0%

Gross Profit

$69.55M

-11.5%

Gross Margin

46.61%

N/A

Market Cap

$236.59MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$81.58K

N/A

Employees

2,900

N/A

Net Income

-$12.89M

+10.7%

EBITDA

$28.54M

-3.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$63.78M

-58.9%

Total Debt

$588.71M

-8.8%

Accounts Receivable

$38.27M

-15.1%

Inventory

$108.80M

+25.2%

Long Term Debt

$564.83M

-7.9%

Short Term Debt

$23.80M

-27.4%

Return on Assets

-11.36%

N/A

Return on Invested Capital

6.05%

N/A

Free Cash Flow

-$13.09M

-155.9%

Operating Cash Flow

-$5.55M

-118.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NWBONorthwest Biotherapeutics, Inc.
$0.16-5.76%
PTCHFPureTech Health plc
$1.80+12.71%
VRNOFVerano Holdings Corp.
$1.30+8.33%
ABTIAlterola Biotech, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About CRLBF

What is the current price of Cresco Labs?

Cresco Labs is trading at $0.64 per share.

What is the 52-week range for Cresco Labs?

Over the past 52 weeks, Cresco Labs has traded between $0.54 and $2.30.

How much debt does Cresco Labs have?

As of the most recent reporting period, Cresco Labs reported total debt of $586.78M.

How much cash does Cresco Labs have on hand?

Cresco Labs reported $63.57M in cash and cash equivalents in its most recent financial results.

What is Cresco Labs’s dividend yield?

Cresco Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services